aluates Reports

$ 0.0

Automative

Global Non-Invasive Cancer Detection Market Research Report 2024

Published Date: October 2024

Report Code: QYRE-Auto-13O18478

BUY CHAPTERS

Global Non-Invasive Cancer Detection Market Research Report 2024

Code: QYRE-Auto-13O18478

Report

October 2024

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Datar Cancer Genetics

Nucleix

miR Scientific

Owlstone Medical

bioAffinity Technologies

Nonacus, Inc.

AMADIX

Trublood

Non-Invasive Cancer Detection Market

Non-invasive cancer testing is a technology that detects cancer by analyzing biomarkers in body fluids such as blood, urine, and saliva without surgery or tissue biopsy. Common non-invasive testing methods include liquid biopsy, genetic testing, and imaging technology, which can detect cancer-related DNA, RNA, proteins, or circulating tumor cells (CTCs) to detect cancer early or monitor disease progression. Non-invasive testing is more comfortable for patients and has lower risks, and is particularly suitable for cancer screening, treatment effect evaluation, and recurrence monitoring.

The global Non-Invasive Cancer Detection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Non-Invasive Cancer Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Non-Invasive Cancer Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Non-Invasive Cancer Detection in Prostate Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Non-Invasive Cancer Detection include Trublood, Datar Cancer Genetics, Nucleix, miR Scientific, Owlstone Medical, bioAffinity Technologies, Nonacus, Amadix, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Non-Invasive Cancer Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Cancer Detection.

The Non-Invasive Cancer Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Invasive Cancer Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-Invasive Cancer Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-Invasive Cancer Detection Market Report

Report Metric	Details
Report Name	Non-Invasive Cancer Detection Market
Segment by Type	Imaging Test Nuclear Medicine Test Others
Segment by Application	Prostate Cancer Bladder Cancer Pancreatic Cancer Breast Cancer Gastric Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Trublood, Datar Cancer Genetics, Nucleix, miR Scientific, Owlstone Medical, bioAffinity Technologies, Nonacus, Amadix
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Invasive Cancer Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Non-Invasive Cancer Detection Market report?

Ans: The main players in the Non-Invasive Cancer Detection Market are Trublood, Datar Cancer Genetics, Nucleix, miR Scientific, Owlstone Medical, bioAffinity Technologies, Nonacus, Amadix

What are the Application segmentation covered in the Non-Invasive Cancer Detection Market report?

Ans: The Applications covered in the Non-Invasive Cancer Detection Market report are Prostate Cancer, Bladder Cancer, Pancreatic Cancer, Breast Cancer, Gastric Cancer, Others

What are the Type segmentation covered in the Non-Invasive Cancer Detection Market report?

Ans: The Types covered in the Non-Invasive Cancer Detection Market report are Imaging Test, Nuclear Medicine Test, Others

Recommended Reports

Non-Invasive Diagnostics

Cancer Detection Technologies

Liquid Biopsy & Molecular

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-Invasive Cancer Detection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Imaging Test

1.2.3 Nuclear Medicine Test

1.2.4 Others

1.3 Market by Application

1.3.1 Global Non-Invasive Cancer Detection Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Prostate Cancer

1.3.3 Bladder Cancer

1.3.4 Pancreatic Cancer

1.3.5 Breast Cancer

1.3.6 Gastric Cancer

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-Invasive Cancer Detection Market Perspective (2019-2030)

2.2 Global Non-Invasive Cancer Detection Growth Trends by Region

2.2.1 Global Non-Invasive Cancer Detection Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Non-Invasive Cancer Detection Historic Market Size by Region (2019-2024)

2.2.3 Non-Invasive Cancer Detection Forecasted Market Size by Region (2025-2030)

2.3 Non-Invasive Cancer Detection Market Dynamics

2.3.1 Non-Invasive Cancer Detection Industry Trends

2.3.2 Non-Invasive Cancer Detection Market Drivers

2.3.3 Non-Invasive Cancer Detection Market Challenges

2.3.4 Non-Invasive Cancer Detection Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-Invasive Cancer Detection Players by Revenue

3.1.1 Global Top Non-Invasive Cancer Detection Players by Revenue (2019-2024)

3.1.2 Global Non-Invasive Cancer Detection Revenue Market Share by Players (2019-2024)

3.2 Global Non-Invasive Cancer Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Non-Invasive Cancer Detection Revenue

3.4 Global Non-Invasive Cancer Detection Market Concentration Ratio

3.4.1 Global Non-Invasive Cancer Detection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Cancer Detection Revenue in 2023

3.5 Global Key Players of Non-Invasive Cancer Detection Head office and Area Served

3.6 Global Key Players of Non-Invasive Cancer Detection, Product and Application

3.7 Global Key Players of Non-Invasive Cancer Detection, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Invasive Cancer Detection Breakdown Data by Type

4.1 Global Non-Invasive Cancer Detection Historic Market Size by Type (2019-2024)

4.2 Global Non-Invasive Cancer Detection Forecasted Market Size by Type (2025-2030)

5 Non-Invasive Cancer Detection Breakdown Data by Application

5.1 Global Non-Invasive Cancer Detection Historic Market Size by Application (2019-2024)

5.2 Global Non-Invasive Cancer Detection Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Non-Invasive Cancer Detection Market Size (2019-2030)

6.2 North America Non-Invasive Cancer Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Non-Invasive Cancer Detection Market Size by Country (2019-2024)

6.4 North America Non-Invasive Cancer Detection Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-Invasive Cancer Detection Market Size (2019-2030)

7.2 Europe Non-Invasive Cancer Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Non-Invasive Cancer Detection Market Size by Country (2019-2024)

7.4 Europe Non-Invasive Cancer Detection Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-Invasive Cancer Detection Market Size (2019-2030)

8.2 Asia-Pacific Non-Invasive Cancer Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Non-Invasive Cancer Detection Market Size by Region (2019-2024)

8.4 Asia-Pacific Non-Invasive Cancer Detection Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-Invasive Cancer Detection Market Size (2019-2030)

9.2 Latin America Non-Invasive Cancer Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Non-Invasive Cancer Detection Market Size by Country (2019-2024)

9.4 Latin America Non-Invasive Cancer Detection Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-Invasive Cancer Detection Market Size (2019-2030)

10.2 Middle East & Africa Non-Invasive Cancer Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Non-Invasive Cancer Detection Market Size by Country (2019-2024)

10.4 Middle East & Africa Non-Invasive Cancer Detection Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Trublood

11.1.1 Trublood Company Details

11.1.2 Trublood Business Overview

11.1.3 Trublood Non-Invasive Cancer Detection Introduction

11.1.4 Trublood Revenue in Non-Invasive Cancer Detection Business (2019-2024)

11.1.5 Trublood Recent Development

11.2 Datar Cancer Genetics

11.2.1 Datar Cancer Genetics Company Details

11.2.2 Datar Cancer Genetics Business Overview

11.2.3 Datar Cancer Genetics Non-Invasive Cancer Detection Introduction

11.2.4 Datar Cancer Genetics Revenue in Non-Invasive Cancer Detection Business (2019-2024)

11.2.5 Datar Cancer Genetics Recent Development

11.3 Nucleix

11.3.1 Nucleix Company Details

11.3.2 Nucleix Business Overview

11.3.3 Nucleix Non-Invasive Cancer Detection Introduction

11.3.4 Nucleix Revenue in Non-Invasive Cancer Detection Business (2019-2024)

11.3.5 Nucleix Recent Development

11.4 miR Scientific

11.4.1 miR Scientific Company Details

11.4.2 miR Scientific Business Overview

11.4.3 miR Scientific Non-Invasive Cancer Detection Introduction

11.4.4 miR Scientific Revenue in Non-Invasive Cancer Detection Business (2019-2024)

11.4.5 miR Scientific Recent Development

11.5 Owlstone Medical

11.5.1 Owlstone Medical Company Details

11.5.2 Owlstone Medical Business Overview

11.5.3 Owlstone Medical Non-Invasive Cancer Detection Introduction

11.5.4 Owlstone Medical Revenue in Non-Invasive Cancer Detection Business (2019-2024)

11.5.5 Owlstone Medical Recent Development

11.6 bioAffinity Technologies

11.6.1 bioAffinity Technologies Company Details

11.6.2 bioAffinity Technologies Business Overview

11.6.3 bioAffinity Technologies Non-Invasive Cancer Detection Introduction

11.6.4 bioAffinity Technologies Revenue in Non-Invasive Cancer Detection Business (2019-2024)

11.6.5 bioAffinity Technologies Recent Development

11.7 Nonacus

11.7.1 Nonacus Company Details

11.7.2 Nonacus Business Overview

11.7.3 Nonacus Non-Invasive Cancer Detection Introduction

11.7.4 Nonacus Revenue in Non-Invasive Cancer Detection Business (2019-2024)

11.7.5 Nonacus Recent Development

11.8 Amadix

11.8.1 Amadix Company Details

11.8.2 Amadix Business Overview

11.8.3 Amadix Non-Invasive Cancer Detection Introduction

11.8.4 Amadix Revenue in Non-Invasive Cancer Detection Business (2019-2024)

11.8.5 Amadix Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Datar Cancer Genetics

Nucleix

miR Scientific

Owlstone Medical

bioAffinity Technologies

Nonacus, Inc.

AMADIX

Trublood

List of Tables

Table 1. Global Non-Invasive Cancer Detection Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Imaging Test

Table 3. Key Players of Nuclear Medicine Test

Table 4. Key Players of Others

Table 5. Global Non-Invasive Cancer Detection Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Non-Invasive Cancer Detection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Non-Invasive Cancer Detection Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Non-Invasive Cancer Detection Market Share by Region (2019-2024)

Table 9. Global Non-Invasive Cancer Detection Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Non-Invasive Cancer Detection Market Share by Region (2025-2030)

Table 11. Non-Invasive Cancer Detection Market Trends

Table 12. Non-Invasive Cancer Detection Market Drivers

Table 13. Non-Invasive Cancer Detection Market Challenges

Table 14. Non-Invasive Cancer Detection Market Restraints

Table 15. Global Non-Invasive Cancer Detection Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Non-Invasive Cancer Detection Market Share by Players (2019-2024)

Table 17. Global Top Non-Invasive Cancer Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Cancer Detection as of 2023)

Table 18. Ranking of Global Top Non-Invasive Cancer Detection Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Non-Invasive Cancer Detection Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Non-Invasive Cancer Detection, Headquarters and Area Served

Table 21. Global Key Players of Non-Invasive Cancer Detection, Product and Application

Table 22. Global Key Players of Non-Invasive Cancer Detection, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Non-Invasive Cancer Detection Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Non-Invasive Cancer Detection Revenue Market Share by Type (2019-2024)

Table 26. Global Non-Invasive Cancer Detection Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Non-Invasive Cancer Detection Revenue Market Share by Type (2025-2030)

Table 28. Global Non-Invasive Cancer Detection Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Non-Invasive Cancer Detection Revenue Market Share by Application (2019-2024)

Table 30. Global Non-Invasive Cancer Detection Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Non-Invasive Cancer Detection Revenue Market Share by Application (2025-2030)

Table 32. North America Non-Invasive Cancer Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Non-Invasive Cancer Detection Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Non-Invasive Cancer Detection Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Non-Invasive Cancer Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Non-Invasive Cancer Detection Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Non-Invasive Cancer Detection Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Non-Invasive Cancer Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Non-Invasive Cancer Detection Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Non-Invasive Cancer Detection Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Non-Invasive Cancer Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Non-Invasive Cancer Detection Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Non-Invasive Cancer Detection Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Non-Invasive Cancer Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Non-Invasive Cancer Detection Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Non-Invasive Cancer Detection Market Size by Country (2025-2030) & (US$ Million)

Table 47. Trublood Company Details

Table 48. Trublood Business Overview

Table 49. Trublood Non-Invasive Cancer Detection Product

Table 50. Trublood Revenue in Non-Invasive Cancer Detection Business (2019-2024) & (US$ Million)

Table 51. Trublood Recent Development

Table 52. Datar Cancer Genetics Company Details

Table 53. Datar Cancer Genetics Business Overview

Table 54. Datar Cancer Genetics Non-Invasive Cancer Detection Product

Table 55. Datar Cancer Genetics Revenue in Non-Invasive Cancer Detection Business (2019-2024) & (US$ Million)

Table 56. Datar Cancer Genetics Recent Development

Table 57. Nucleix Company Details

Table 58. Nucleix Business Overview

Table 59. Nucleix Non-Invasive Cancer Detection Product

Table 60. Nucleix Revenue in Non-Invasive Cancer Detection Business (2019-2024) & (US$ Million)

Table 61. Nucleix Recent Development

Table 62. miR Scientific Company Details

Table 63. miR Scientific Business Overview

Table 64. miR Scientific Non-Invasive Cancer Detection Product

Table 65. miR Scientific Revenue in Non-Invasive Cancer Detection Business (2019-2024) & (US$ Million)

Table 66. miR Scientific Recent Development

Table 67. Owlstone Medical Company Details

Table 68. Owlstone Medical Business Overview

Table 69. Owlstone Medical Non-Invasive Cancer Detection Product

Table 70. Owlstone Medical Revenue in Non-Invasive Cancer Detection Business (2019-2024) & (US$ Million)

Table 71. Owlstone Medical Recent Development

Table 72. bioAffinity Technologies Company Details

Table 73. bioAffinity Technologies Business Overview

Table 74. bioAffinity Technologies Non-Invasive Cancer Detection Product

Table 75. bioAffinity Technologies Revenue in Non-Invasive Cancer Detection Business (2019-2024) & (US$ Million)

Table 76. bioAffinity Technologies Recent Development

Table 77. Nonacus Company Details

Table 78. Nonacus Business Overview

Table 79. Nonacus Non-Invasive Cancer Detection Product

Table 80. Nonacus Revenue in Non-Invasive Cancer Detection Business (2019-2024) & (US$ Million)

Table 81. Nonacus Recent Development

Table 82. Amadix Company Details

Table 83. Amadix Business Overview

Table 84. Amadix Non-Invasive Cancer Detection Product

Table 85. Amadix Revenue in Non-Invasive Cancer Detection Business (2019-2024) & (US$ Million)

Table 86. Amadix Recent Development

Table 87. Research Programs/Design for This Report

Table 88. Key Data Information from Secondary Sources

Table 89. Key Data Information from Primary Sources

Table 90. Authors List of This Report

List of Figures

Figure 1. Non-Invasive Cancer Detection Picture

Figure 2. Global Non-Invasive Cancer Detection Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Non-Invasive Cancer Detection Market Share by Type: 2023 VS 2030

Figure 4. Imaging Test Features

Figure 5. Nuclear Medicine Test Features

Figure 6. Others Features

Figure 7. Global Non-Invasive Cancer Detection Market Size by Application (2024-2030) & (US$ Million)

Figure 8. Global Non-Invasive Cancer Detection Market Share by Application: 2023 VS 2030

Figure 9. Prostate Cancer Case Studies

Figure 10. Bladder Cancer Case Studies

Figure 11. Pancreatic Cancer Case Studies

Figure 12. Breast Cancer Case Studies

Figure 13. Gastric Cancer Case Studies

Figure 14. Others Case Studies

Figure 15. Non-Invasive Cancer Detection Report Years Considered

Figure 16. Global Non-Invasive Cancer Detection Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Non-Invasive Cancer Detection Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Non-Invasive Cancer Detection Market Share by Region: 2023 VS 2030

Figure 19. Global Non-Invasive Cancer Detection Market Share by Players in 2023

Figure 20. Global Top Non-Invasive Cancer Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Cancer Detection as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Non-Invasive Cancer Detection Revenue in 2023

Figure 22. North America Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Non-Invasive Cancer Detection Market Share by Country (2019-2030)

Figure 24. United States Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Non-Invasive Cancer Detection Market Share by Country (2019-2030)

Figure 28. Germany Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Non-Invasive Cancer Detection Market Share by Region (2019-2030)

Figure 36. China Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Japan Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. South Korea Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. India Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Australia Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Non-Invasive Cancer Detection Market Share by Country (2019-2030)

Figure 44. Mexico Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Brazil Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Non-Invasive Cancer Detection Market Share by Country (2019-2030)

Figure 48. Turkey Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. UAE Non-Invasive Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Trublood Revenue Growth Rate in Non-Invasive Cancer Detection Business (2019-2024)

Figure 52. Datar Cancer Genetics Revenue Growth Rate in Non-Invasive Cancer Detection Business (2019-2024)

Figure 53. Nucleix Revenue Growth Rate in Non-Invasive Cancer Detection Business (2019-2024)

Figure 54. miR Scientific Revenue Growth Rate in Non-Invasive Cancer Detection Business (2019-2024)

Figure 55. Owlstone Medical Revenue Growth Rate in Non-Invasive Cancer Detection Business (2019-2024)

Figure 56. bioAffinity Technologies Revenue Growth Rate in Non-Invasive Cancer Detection Business (2019-2024)

Figure 57. Nonacus Revenue Growth Rate in Non-Invasive Cancer Detection Business (2019-2024)

Figure 58. Amadix Revenue Growth Rate in Non-Invasive Cancer Detection Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Noninvasive Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Liquid Biopsy For Cancer Diagnostics Market Research Report 2024

Global Noninvasive Cancer Biomarkers Market Research Report 2024

Global Canine Cancer Detection Market Research Report 2024

Non Invasive Cancer Diagnostics Market

Non Invasive Prenatal Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Canine Tumor Screening Market Research Report 2024

Global Canine Fluid Biopsy Market Research Report 2025

Global Canine Liquid Biopsy Market Research Report 2024

Global Liquid Tumor Biopsy Market Research Report 2024

Global Canine Biopsy Services Market Research Report 2025

Global Multi Cancer Detection Blood Test Market Research Report 2024

Global Non invasive Diagnosis Market Research Report 2025

Global Cell free Tumor DNA Detection Market Research Report 2025

Global Circulating Tumor DNA Diagnostics Market Research Report 2025

Global Cell Free DNA cfDNA Testing Market Research Report 2024

Global Mobile Cancer Screening Devices Market Insights Forecast to 2030

Global Non Invasive Prenatal DNA Testing Service Market Research Report 2024

Global Liquid Biopsy Products Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions